This session will provide an insight into the complex regulatory issues associated with switching of medicines to OTC status and strategic insights into how to use OTC switching to extend protection against competitor companies as patent expiry approaches.

Learning Objectives:
Discuss the rationale behind government support for OTC switches and commercial case for switching
Discuss successes and failures with case studies of recent switches.